Novartis (NVS) Tops Q3 EPS by 4c

Novartis (NYSE: NVS) reported Q3 EPS of $1.29, $0.04 better than the analyst estimate of $1.25. Revenue for the quarter came in at $12.41 billion versus the consensus estimate of $12.25 billion.

2017 Group outlook re-confirmed; net sales expected to be broadly in line with prior year (cc), core operating income expected to be broadly in line or decline low single digit (cc).

For earnings history and earnings-related data on Novartis (NVS) click here.

You May Also Be Interested In

• ​Trump said he was unaware of his earnings from crypto
• FactSet (FDS) Tops Q3 EPS by 8c ; Offers Guidance
• Lucid reports Q2 output, names new CFO and five other leaders